カテゴリー： 世界, 医療/バイオ, MarketsandMarkets

世界の経皮吸収パッチ市場（～2029年）：種類別（貼付剤、マトリックス、リザーバー膜）、粘着剤別（アクリル、シリコーン、ハイドロゲル）、用途別（疼痛、CVS、ホルモン）、流通チャネル別（薬局（オンライン小売、病院））、エンドユーザー別

【英語タイトル】Transdermal Patches Market by Type (Drug-in-adhesives, Matrix, Reservoir Membrane), Adhesive (Acrylic, Silicone, Hydrogel), Application (Pain, CVS, Hormonal), Distribution Channel (Pharmacy (Retail Online, Hospital)), End User - Global Forecast to 2029

MarketsandMarketsが出版した調査資料（MD8869-24）・商品コード：MD8869-24
・発行会社（調査会社）：MarketsandMarkets
・発行日：2023年11月30日
・ページ数：282
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥742,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥997,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,222,500見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

“経皮吸収パッチの世界市場は、2023年の62億米ドルから2029年には80億米ドルに達し、2023年から2029年までの年平均成長率は4.5％になると予測“世界の経皮吸収パッチ市場の成長を促進する要因は、慢性疾患の有病率の上昇、鎮痛パッチの使用拡大、経皮吸収パッチの技術進歩、従来の注射から経皮吸収パッチへの移行などです。とはいえ、予想される期間中、薬剤の不具合、経皮薬物送達システムのリコール、医療施設費用の増加などの要因は、おそらく市場の拡大をある程度抑制するでしょう。

“経皮吸収パッチ市場のパッチタイプではマトリックスパッチ分野が最も高いCAGRで成長する見込み”
パッチの魅力と有効性を高める多くの特性により、マトリックスパッチ分野は経皮吸収パッチ市場で最も高いCAGRで成長する見込みです。マトリックスパッチでは、薬剤はポリマーマトリックス内に均一に分散され、わかりやすく効果的な設計となっています。このデザインは、薬効成分の長時間調節された放出を可能にすることで、皮膚からの薬物吸収を可能な限り促進します。マトリックスパッチはその適応性の高さから、様々な治療分野で広く使用されています。これは、マトリックスパッチが幅広い薬物の投与に使用される可能性があるためです。患者のコンプライアンスとマトリックスパッチの有効性は、マトリックスパッチの処方と製造における継続的な技術改良の結果、高まっています。

“経皮吸収パッチ市場の粘着剤タイプでは、シリコーン粘着剤分野が最も高いCAGRで成長する見込み”
シリコーン粘着剤は他の粘着剤と比較して特別な利点があるため、経皮吸収パッチ市場の粘着剤タイプではシリコーン粘着パッチ分野が最も高いCAGRで成長すると予想されます。シリコーン粘着剤は、皮膚と薄いながらも強固な接続を形成することで、患者の快適性と粘着性を確保します。生体適合性があり低刺激性であるため、皮膚過敏症や炎症の可能性が低く、幅広い患者に使用することができます。シリコーン粘着パッチの適合性と柔軟性により、より快適な装着感が得られ、長期的かつ定期的な使用が可能になります。

“アプリケーションの種類に基づいて、疼痛管理セグメントは、経皮吸収パッチ市場で最も高いCAGRで成長することが期待される”
経皮吸収パッチ市場は、安全で非侵襲的な疼痛緩和オプションに対するニーズの高まりにより、疼痛管理セグメントにおいて最も高いCAGRで成長する見込みです。痛みを和らげる経皮吸収パッチは、鎮痛薬を皮膚から標的を定めて放出することで、均一で安定した治療効果をもたらします。この方法は、侵襲的な治療や従来の経口薬に代わる選択肢を提供し、慢性的な疼痛障害を抱える人々にとって特に魅力的です。

“流通チャネルに基づくと、オンライン薬局セグメントが経皮吸収パッチ市場で最も高いCAGRで成長する見込み”
経皮吸収パッチの流通チャネルとして、オンライン薬局セグメントは市場で最も速い速度で成長すると予測されています。これは、デジタル化の一般的な傾向と、ヘルスケアアイテムのeコマースプラットフォームへの依存が高まっているためです。顧客は、オンライン薬局の助けを借りて、自宅から簡単かつ便利に経皮吸収パッチを入手することができます。Eコマースの人気の高まりは、その便利な注文や宅配機能とともに、手間をかけずに医療を受けたいという患者のニーズの変化に対応しています。

“エンドユーザーに基づくと、経皮吸収パッチ市場で最も高いCAGRで成長すると予想されるのは、ホームケア設定セグメント”
患者中心で個別化された医療を目指す傾向が強まっていることから、経皮吸収パッチ市場のホームケア設定分野は、エンドユーザーとして最も高い成長率が見込まれています。経皮吸収型パッチは、便利で非侵襲的な投薬方法を提供するため、家庭内での自己投与に特に適しています。高齢化社会と慢性疾患の増加により、利用しやすく長期的な治療に代わる薬へのニーズが高まっています。経皮吸収型テープ製剤は、このようなヘルスケアの新しいパラダイムに完璧に適合しています。

“予測期間中、アジア太平洋が経皮吸収パッチ市場で最も高いCAGRで成長”
アジア太平洋の経皮吸収パッチ市場は、同地域のヘルスケア状況の変化を浮き彫りにする様々な要因により、最も高いCAGRで成長する見込みです。経皮吸収パッチは、慢性疾患の罹患率の上昇や、非侵襲的な薬物送達技術に関する知識の高まりにより、ますます普及しています。この地域の人口の多さと高齢化は、医療費高騰の主な要因であり、その結果、利用しやすく患者に優しい治療の選択肢に対する需要が高まっています。アジア太平洋の経皮吸収型テープ製剤市場も、医薬品の研究開発におけるブレークスルー、可処分所得の増加、医療インフラの改善などの結果、拡大が見込まれています。

本レポートで参照した経皮吸収型テープ製剤市場の主要参入企業（供給側）の内訳は以下の通りです：
- 企業タイプ別：ティア1-45％、ティア2-30％、ティア3-25％
- 役職別：Cレベル-42％、ディレクターレベル-29％、その他-29％
- 地域別：北米-30％、ヨーロッパ-25％、アジア太平洋-30％、中南米-10％、中東・アフリカ-5％

経皮吸収型テープ製剤市場における主なプレーヤーは、Johnson & Johnson (U.S.), Viatris Inc. (U.S.), Hisamatsu Pharmaceuticals Co. Ltd. (Japan), Cipla Inc. (India), Teva Pharmaceutical Industries Ltd. (Israel), Agile Therapeutics (U.S.), Bayer AG (Germany), Luye Pharma Group (China), Sparsha Pharma International Pvt Ltd (India), Iontopatch (U.S.), Medherant Limited (U.K.), AdhexPharma (France), Evernow (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Alvogen Group Inc. (U.S.), Novartis AG (Switzerland), AbbVie Inc. (U.S.), Nitto Denko Corporation (Japan), USB S.A. (Belgium), Boehringer Ingelheim International GmbH (Germany), Endo International plc. (Ireland), LEAD CHEMICAL Co., Ltd. (Japan), Purdue Pharma L.P (U.S.) and Mundipharma International (U.K.)などが含まれます。

調査対象範囲：
この調査レポートは、様々なセグメントにわたる経皮吸収パッチ市場を対象としています。パッチタイプ、粘着剤タイプ、用途、流通タイプ、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模および市場の成長可能性を推定することを目的としています。また、市場主要企業の詳細な競合分析、企業プロフィール、製品・事業内容に関する主な考察、最近の動向、主要市場戦略も掲載しています。

レポートを購入する理由：
本レポートは、経皮吸収パッチ市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供し、この市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、当レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します：
- 主な促進要因（慢性疾患の有病率の増加、鎮痛パッチの採用拡大、経皮吸収パッチの技術進歩、従来の針注射から経皮吸収パッチへの切り替え）、阻害要因（血管手術および関連製品の処置コストの高さ、 機会（製薬会社とドラッグデリバリ企業間の提携、自己投与および在宅ケア用ドラッグデリバリシステム）、課題（皮膚刺激性および浸透性に関する技術的障壁、熟練した専門家の不足）を分析をしています。
- 市場への浸透： 経皮吸収パッチの世界市場におけるトップ企業が提供する製品ポートフォリオに関する包括的な情報を提供します。パッチタイプ別、粘着剤タイプ別、用途別、流通チャネル別、エンドユーザー別、地域別に市場を分析しています。
- 製品の強化/革新： 経皮吸収パッチの世界市場における今後の動向や製品発売に関する詳細な洞察を記載しています。
- 市場開発： パッチタイプ別、粘着剤タイプ別、用途別、流通チャネル別、エンドユーザー別、地域別の有利な新興市場に関する包括的情報を提供します。
- 市場の多様化： 世界の経皮吸収型テープ製剤市場における新製品やサービス、成長地域、最近の動向、投資に関する詳細な情報を提供します。
- 競合評価： 経皮吸収パッチの世界市場における主要企業の市場シェア、成長戦略、製品・サービス提供、能力を詳細に評価しています。

1.　イントロダクション
2.　調査方法
3.　エグゼクティブサマリー
4.　プレミアムインサイト
5.　市場概要
6.　世界の経皮吸収パッチ市場規模：パッチ種類別
7.　世界の経皮吸収パッチ市場規模：粘着剤別
8.　世界の経皮吸収パッチ市場規模：用途別
9.　世界の経皮吸収パッチ市場規模：流通チャネル別
10.　世界の経皮吸収パッチ市場規模：エンドユーザー別
11.　世界の経皮吸収パッチ市場規模：地域別
12.　競争環境
13.　企業情報
14.　付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 27
1.3 MARKET SCOPE 27
1.3.1 INCLUSIONS AND EXCLUSIONS OF STUDY 27
1.3.2 MARKETS COVERED 28
1.3.3 YEARS CONSIDERED 28
1.4 CURRENCY 29
TABLE 1 STANDARD CURRENCY CONVERSION RATES 29
1.5 STAKEHOLDERS 29
1.6 RECESSION IMPACT 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 1 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 33
FIGURE 2 PRIMARY SOURCES 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 34
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 35
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 36
2.2 MARKET SIZE ESTIMATION 36
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: JOHNSON & JOHNSON 37
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: TRANSDERMAL PATCHES MARKET (2022) 38
FIGURE 9 BOTTOM-UP APPROACH 39
FIGURE 10 TOP-DOWN APPROACH 39
FIGURE 11 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2029) 40
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 41
FIGURE 13 DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET SHARE ESTIMATION 43
2.5 ASSUMPTIONS FOR STUDY 43
2.6 RESEARCH LIMITATIONS 43
2.6.1 SCOPE-RELATED LIMITATIONS 43
2.6.2 METHODOLOGY-RELATED LIMITATIONS 44
2.7 RISK ASSESSMENT 44
TABLE 2 RISK ASSESSMENT: TRANSDERMAL PATCHES MARKET 44
2.8 IMPACT OF RECESSION ON TRANSDERMAL PATCHES MARKET 45
3 EXECUTIVE SUMMARY 46
FIGURE 14 TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2023 VS. 2029 (USD MILLION) 46
FIGURE 15 TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2023 VS. 2029 (USD MILLION) 47
FIGURE 16 TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION) 47
FIGURE 17 TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2023 VS. 2029 (USD MILLION) 48
FIGURE 18 TRANSDERMAL PATCHES MARKET, BY END USER, 2023 VS. 2029 (USD MILLION) 49
FIGURE 19 GEOGRAPHICAL SNAPSHOT OF TRANSDERMAL PATCHES MARKET 50
4 PREMIUM INSIGHTS 51
4.1 TRANSDERMAL PATCHES MARKET OVERVIEW 51
FIGURE 20 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 51
4.2 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE AND COUNTRY (2022) 52
FIGURE 21 DRUG-IN-ADHESIVE PATCHES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 52
4.3 TRANSDERMAL PATCHES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 53
FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 53
4.4 TRANSDERMAL PATCHES MARKET, REGIONAL MIX, 2021−2029 53
FIGURE 23 NORTH AMERICA WILL CONTINUE TO DOMINATE TRANSDERMAL PATCHES MARKET DURING FORECAST PERIOD 53
4.5 TRANSDERMAL PATCHES MARKET: DEVELOPING VS. DEVELOPED MARKETS 54
FIGURE 24 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 25 TRANSDERMAL PATCHES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Increasing prevalence of chronic diseases 56
5.2.1.2 Growing adoption of analgesic patches 56
5.2.1.3 Technological advancements in transdermal patches 56
5.2.1.4 Switching from conventional needle injections to transdermal patches 57
5.2.2 RESTRAINTS 57
5.2.2.1 High procedural cost of transdermal surgeries and associated products 57
5.2.2.2 Drug failure and recalls of transdermal drug delivery systems 57
5.2.2.3 Rising cost of healthcare facilities 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Collaborations between pharmaceutical companies and drug delivery firms 58
5.2.3.2 Self-administration and home care drug delivery systems 59
5.2.4 CHALLENGES 59
5.2.4.1 Technical barriers related to skin irritation and permeability 59
5.2.4.2 Lack of skilled professionals 60
5.3 TECHNOLOGY ANALYSIS 60
5.4 INDUSTRY TRENDS 60
5.4.1 ADVANCEMENTS IN TRANSDERMAL DRUG DELIVERY SYSTEMS 60
5.5 VALUE CHAIN ANALYSIS 61
FIGURE 26 TRANSDERMAL PATCHES MARKET: VALUE CHAIN ANALYSIS 61
5.6 SUPPLY CHAIN ANALYSIS 62
FIGURE 27 TRANSDERMAL PATCHES MARKET: SUPPLY CHAIN ANALYSIS 63
5.7 TRADE ANALYSIS 63
5.7.1 TRADE ANALYSIS FOR TRANSDERMAL PATCHES 63
TABLE 3 IMPORT AND EXPORT DATA FOR TRANSDERMAL PATCHES, BY COUNTRY, 2022 63
5.8 PORTER’S FIVE FORCES ANALYSIS 64
TABLE 4 TRANSDERMAL PATCHES MARKET: PORTER’S FIVE FORCES ANALYSIS 64
5.8.1 THREAT OF NEW ENTRANTS 64
5.8.2 THREAT OF SUBSTITUTES 64
5.8.3 BARGAINING POWER OF BUYERS 64
5.8.4 BARGAINING POWER OF SUPPLIERS 65
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 65
5.9 TARIFF AND REGULATORY LANDSCAPE 65
5.9.1 REGULATORY ANALYSIS 65
5.9.1.1 North America 65
5.9.1.1.1 US 65
5.9.1.1.2 Canada 65
5.9.1.2 Europe 65
5.9.1.3 Asia Pacific 66
5.9.1.3.1 China 66
5.9.1.3.2 Japan 66
5.9.1.3.3 India 66
5.9.1.4 Latin America 66
5.9.1.4.1 Brazil 66
5.9.1.4.2 Mexico 66
5.9.1.5 Middle East 67
5.9.1.6 Africa 67
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
5.10 PATENT ANALYSIS 69
5.10.1 PATENT PUBLICATION TRENDS FOR TRANSDERMAL PATCHES 69
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2015–DECEMBER 2022) 69
5.10.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN TRANSDERMAL PATCHES MARKET 70
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTES) FOR TRANSDERMAL PATCH PATENTS (JANUARY 2015–DECEMBER 2022) 70
FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR TRANSDERMAL PATCHES (JANUARY 2015–APRIL 2022) 71
5.11 PRICING ANALYSIS 71
TABLE 10 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY APPLICATION 72
TABLE 11 REGIONAL PRICING ANALYSIS OF TRANSDERMAL PATCHES, 2023 (USD) 73
5.12 KEY CONFERENCES & EVENTS IN 2023–2024 74
TABLE 12 TRANSDERMAL PATCHES MARKET: DETAILED LIST OF CONFERENCES & EVENTS 74
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 75
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 75
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TRANSDERMAL PATCHES 75
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TRANSDERMAL PATCHES 75
5.13.2 BUYING CRITERIA 75
FIGURE 32 KEY BUYING CRITERIA FOR TRANSDERMAL PATCHES 75
TABLE 14 KEY BUYING CRITERIA FOR TRANSDERMAL PATCHES 76
5.14 ECOSYSTEM/MARKET MAP 76
FIGURE 33 TRANSDERMAL PATCHES MARKET: ECOSYSTEM/MARKET MAP 76
5.15 ADJACENT MARKET ANALYSIS 77
FIGURE 34 TRANSDERMAL PATCHES MARKET: ADJACENT MARKETS 77
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 77
FIGURE 35 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 78
5.17 UNMET NEEDS 78
6 TRANSDERMAL PATCHES MARKET, BY PATCH TYPE 79
6.1 INTRODUCTION 80
TABLE 15 TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 80
6.2 DRUG-IN-ADHESIVE PATCHES 80
TABLE 16 DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 81
TABLE 17 DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 81
6.2.1 SINGLE-LAYER DRUG-IN-ADHESIVE PATCHES 82
6.2.1.1 Used to deliver wide range of medications 82
TABLE 18 SINGLE-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 82
6.2.2 MULTI-LAYER DRUG-IN-ADHESIVE PATCHES 83
6.2.2.1 Enhanced drug release and reduced side effects to drive adoption 83
TABLE 19 MULTI-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 84
6.3 MATRIX PATCHES 85
6.3.1 TECHNOLOGICAL ADVANCEMENTS IN NEW MATRIX MATERIALS TO SUPPORT MARKET GROWTH 85
TABLE 20 MATRIX TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 85
6.4 RESERVOIR MEMBRANE PATCHES 86
6.4.1 OFFER GREAT CONTROL OVER DRUG DELIVERY RATES 86
TABLE 21 RESERVOIR MEMBRANE TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 86
6.5 MICRONEEDLE PATCHES 87
6.5.1 ABILITY TO DELIVER ACTIVE PHARMACEUTICAL INGREDIENTS TO BOOST ADOPTION 87
TABLE 22 MICRONEEDLE TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 87
6.6 IONTOPHORESIS PATCHES 88
6.6.1 USED TO DELIVER MEDICINES WITH LOW MOLECULAR WEIGHT 88
TABLE 23 IONTOPHORESIS TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 88
6.7 VAPOR PATCHES 89
6.7.1 RELEASE ESSENTIAL OILS FOR UP TO 6 HOURS 89
TABLE 24 VAPOR TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 89
 
7 TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE 90
7.1 INTRODUCTION 91
TABLE 25 TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 91
7.2 ACRYLIC ADHESIVES 91
7.2.1 HIGH DURABILITY TO BOOST DEMAND 91
TABLE 26 TRANSDERMAL PATCHES MARKET FOR ACRYLIC ADHESIVES, BY COUNTRY, 2021–2029 (USD MILLION) 92
7.3 SILICONE ADHESIVES 92
7.3.1 LOW PEEL ADHESION PROPERTY MAKES IT IDEAL FOR MEDICAL APPLICATIONS 92
TABLE 27 TRANSDERMAL PATCHES MARKET FOR SILICONE ADHESIVES, BY COUNTRY, 2021–2029 (USD MILLION) 93
7.4 HYDROGEL ADHESIVES 94
7.4.1 INCREASING DEMAND FOR TRANSDERMAL DRUG DELIVERY SYSTEMS TO DRIVE MARKET 94
TABLE 28 TRANSDERMAL PATCHES MARKET FOR HYDROGEL ADHESIVES, BY COUNTRY, 2021–2029 (USD MILLION) 94
7.5 OTHER ADHESIVES 95
TABLE 29 TRANSDERMAL PATCHES MARKET FOR OTHER ADHESIVES, BY COUNTRY, 2021–2029 (USD MILLION) 95
8 TRANSDERMAL PATCHES MARKET, BY APPLICATION 96
8.1 INTRODUCTION 97
TABLE 30 TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 97
8.2 PAIN MANAGEMENT 97
8.2.1 HIGH BURDEN OF CHRONIC PAIN WORLDWIDE TO DRIVE MARKET 97
TABLE 31 TRANSDERMAL PATCHES AVAILABLE FOR PAIN MANAGEMENT 98
TABLE 32 TRANSDERMAL PATCHES MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2021–2029 (USD MILLION) 98
8.3 SMOKING CESSATION 99
8.3.1 CONTROLLED DRUG DELIVERY AND REDUCED SIDE EFFECTS TO SUPPORT MARKET GROWTH 99
TABLE 33 TRANSDERMAL PATCHES AVAILABLE FOR SMOKING CESSATION 99
TABLE 34 TRANSDERMAL PATCHES MARKET FOR SMOKING CESSATION, BY COUNTRY, 2021–2029 (USD MILLION) 100
8.4 HORMONE REPLACEMENT THERAPY 100
TABLE 35 TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 101
TABLE 36 TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY COUNTRY, 2021–2029 (USD MILLION) 101
8.4.1 TRANSDERMAL TESTOSTERONE THERAPY 102
8.4.1.1 Increased bone density, better muscle development, and reduced risk factors to support market growth 102
TABLE 37 TRANSDERMAL PATCHES AVAILABLE FOR TRANSDERMAL TESTOSTERONE THERAPY 102
TABLE 38 TRANSDERMAL PATCHES MARKET FOR TRANSDERMAL TESTOSTERONE THERAPY, BY COUNTRY, 2021–2029 (USD MILLION) 102
8.4.2 TRANSDERMAL ESTROGEN THERAPY 103
8.4.2.1 Growing use of transdermal contraceptive patches to drive market 103
TABLE 39 TRANSDERMAL PATCHES AVAILABLE FOR TRANSDERMAL ESTROGEN THERAPY 103
TABLE 40 TRANSDERMAL PATCHES MARKET FOR TRANSDERMAL ESTROGEN THERAPY, BY COUNTRY, 2021–2029 (USD MILLION) 104
8.5 CENTRAL NERVOUS SYSTEM DISORDERS 104
8.5.1 EASE OF USE, SIMPLE TREATMENT REGIMEN, AND CONTINUOUS DELIVERY OF DRUGS TO DRIVE ADOPTION 104
TABLE 41 TRANSDERMAL PATCHES AVAILABLE FOR CENTRAL NERVOUS SYSTEM DISORDERS 105
TABLE 42 TRANSDERMAL PATCHES MARKET FOR CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY, 2021–2029 (USD MILLION) 105
8.6 CARDIOVASCULAR DISEASES 106
8.6.1 AVAILABILITY OF ALTERNATIVE AND ADVANCED DRUG DELIVERY OPTIONS TO LIMIT MARKET GROWTH 106
TABLE 43 TRANSDERMAL PATCHES AVAILABLE FOR CARDIOVASCULAR DISEASES 106
TABLE 44 TRANSDERMAL PATCHES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2029 (USD MILLION) 107
8.7 OTHER APPLICATIONS 107
TABLE 45 TRANSDERMAL PATCHES AVAILABLE FOR OTHER APPLICATIONS 108
TABLE 46 TRANSDERMAL PATCHES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 108
9 TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL 109
9.1 INTRODUCTION 110
TABLE 47 TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 110
9.2 HOSPITAL PHARMACIES 110
9.2.1 LARGEST DISTRIBUTION CHANNEL FOR TRANSDERMAL PATCHES 110
TABLE 48 TRANSDERMAL PATCHES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021–2029 (USD MILLION) 111
9.3 RETAIL PHARMACIES 111
9.3.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET 111
TABLE 49 TRANSDERMAL PATCHES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2021–2029 (USD MILLION) 112
9.4 ONLINE PHARMACIES 112
9.4.1 FASTEST-GROWING SEGMENT DUE TO EASY ACCESSIBILITY TO MEDICATIONS 112
TABLE 50 TRANSDERMAL PATCHES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2021–2029 (USD MILLION) 113
 
10 TRANSDERMAL PATCHES MARKET, BY END USER 114
10.1 INTRODUCTION 115
TABLE 51 TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 115
10.2 HOME CARE SETTINGS 115
10.2.1 RAPID GROWTH IN GERIATRIC POPULATION TO SUPPORT MARKET GROWTH 115
TABLE 52 TRANSDERMAL PATCHES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2029 (USD MILLION) 116
10.3 HOSPITALS & CLINICS 117
10.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 117
TABLE 53 TRANSDERMAL PATCHES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2029 (USD MILLION) 118
11 TRANSDERMAL PATCHES MARKET, BY REGION 119
11.1 INTRODUCTION 120
TABLE 54 TRANSDERMAL PATCHES MARKET, BY REGION, 2021–2029 (USD MILLION) 120
11.2 NORTH AMERICA 121
11.2.1 IMPACT OF RECESSION ON NORTH AMERICAN TRANSDERMAL PATCHES MARKET 121
FIGURE 36 NORTH AMERICA: TRANSDERMAL PATCHES MARKET SNAPSHOT 122
TABLE 55 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 123
TABLE 56 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 123
TABLE 57 NORTH AMERICA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 124
TABLE 58 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 124
TABLE 59 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 125
TABLE 60 NORTH AMERICA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 125
TABLE 61 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 126
TABLE 62 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 126
11.2.2 US 126
11.2.2.1 Largest market for transdermal patches 126
TABLE 63 US: MACROECONOMIC INDICATORS 127
TABLE 64 US: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 127
TABLE 65 US: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 128
TABLE 66 US: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 128
TABLE 67 US: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 129
TABLE 68 US: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 129
TABLE 69 US: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 130
TABLE 70 US: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 130
11.2.3 CANADA 130
11.2.3.1 Rising funding for transdermal drug delivery research to drive market 130
TABLE 71 CANADA: MACROECONOMIC INDICATORS 131
TABLE 72 CANADA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 131
TABLE 73 CANADA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 131
TABLE 74 CANADA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 132
TABLE 75 CANADA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 132
TABLE 76 CANADA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 133
TABLE 77 CANADA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 133
TABLE 78 CANADA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 133
11.3 EUROPE 134
11.3.1 IMPACT OF RECESSION ON EUROPEAN TRANSDERMAL PATCHES MARKET 134
TABLE 79 EUROPE: TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 135
TABLE 80 EUROPE: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 135
TABLE 81 EUROPE: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 136
TABLE 82 EUROPE: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 136
TABLE 83 EUROPE: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 137
TABLE 84 EUROPE: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 137
TABLE 85 EUROPE: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 138
TABLE 86 EUROPE: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 138
11.3.2 GERMANY 138
11.3.2.1 Favorable government policies to aid market growth 138
TABLE 87 GERMANY: MACROECONOMIC INDICATORS 139
TABLE 88 GERMANY: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 139
TABLE 89 GERMANY: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 140
TABLE 90 GERMANY: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 140
TABLE 91 GERMANY: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 141
TABLE 92 GERMANY: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 141
TABLE 93 GERMANY: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 142
TABLE 94 GERMANY: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 142
11.3.3 UK 142
11.3.3.1 Increasing funding for R&D of innovative transdermal technologies to drive market 142
TABLE 95 UK: MACROECONOMIC INDICATORS 143
TABLE 96 UK: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 143
TABLE 97 UK: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 143
TABLE 98 UK: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 144
TABLE 99 UK: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 144
TABLE 100 UK: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 144
TABLE 101 UK: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 145
TABLE 102 UK: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 145
11.3.4 FRANCE 145
11.3.4.1 Development of transdermal drug delivery systems by local players to support market growth 145
TABLE 103 FRANCE: MACROECONOMIC INDICATORS 146
TABLE 104 FRANCE: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 146
TABLE 105 FRANCE: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 147
TABLE 106 FRANCE: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 147
TABLE 107 FRANCE: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 148
TABLE 108 FRANCE: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 148
TABLE 109 FRANCE: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 149
TABLE 110 FRANCE: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 149
11.3.5 ITALY 149
11.3.5.1 High burden of lung cancer to propel market 149
TABLE 111 ITALY: MACROECONOMIC INDICATORS 150
TABLE 112 ITALY: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 150
TABLE 113 ITALY: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 150
TABLE 114 ITALY: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 151
TABLE 115 ITALY: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 151
TABLE 116 ITALY: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 151
TABLE 117 ITALY: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 152
TABLE 118 ITALY: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 152
11.3.6 SPAIN 152
11.3.6.1 Growing demand for self-care and personalized medicine to drive market 152
TABLE 119 SPAIN: MACROECONOMIC INDICATORS 153
TABLE 120 SPAIN: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 153
TABLE 121 SPAIN: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 153
TABLE 122 SPAIN: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 154
TABLE 123 SPAIN: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 154
TABLE 124 SPAIN: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 155
TABLE 125 SPAIN: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 155
TABLE 126 SPAIN: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 155
11.3.7 REST OF EUROPE 156
TABLE 127 REST OF EUROPE: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 156
TABLE 128 REST OF EUROPE: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 156
TABLE 129 REST OF EUROPE: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 157
TABLE 130 REST OF EUROPE: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 157
TABLE 131 REST OF EUROPE: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 158
TABLE 132 REST OF EUROPE: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL 2021–2029 (USD MILLION) 158
TABLE 133 REST OF EUROPE: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 158
11.4 ASIA PACIFIC 159
11.4.1 IMPACT OF RECESSION ON ASIA PACIFIC TRANSDERMAL PATCHES MARKET 159
FIGURE 37 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET SNAPSHOT 160
TABLE 134 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 161
TABLE 135 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 161
TABLE 136 ASIA PACIFIC: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 162
TABLE 137 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 162
TABLE 138 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 163
TABLE 139 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 163
TABLE 140 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 164
TABLE 141 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 164
11.4.2 CHINA 164
11.4.2.1 Large diabetic population to drive market 164
TABLE 142 CHINA: MACROECONOMIC INDICATORS 165
TABLE 143 CHINA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 165
TABLE 144 CHINA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 166
TABLE 145 CHINA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 166
TABLE 146 CHINA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 167
TABLE 147 CHINA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 167
TABLE 148 CHINA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 167
TABLE 149 CHINA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 168
11.4.3 JAPAN 168
11.4.3.1 Increasing number of product approvals and growing focus of local players on R&D of transdermal systems to support market growth 168
TABLE 150 JAPAN: MACROECONOMIC INDICATORS 168
TABLE 151 JAPAN: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 169
TABLE 152 JAPAN: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 169
TABLE 153 JAPAN: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 170
TABLE 154 JAPAN: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 170
TABLE 155 JAPAN: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 171
TABLE 156 JAPAN: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 171
TABLE 157 JAPAN: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 171
11.4.4 INDIA 172
11.4.4.1 Increasing focus on noninvasive methods of drug delivery to drive market 172
TABLE 158 INDIA: MACROECONOMIC INDICATORS 172
TABLE 159 INDIA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 172
TABLE 160 INDIA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 173
TABLE 161 INDIA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 173
TABLE 162 INDIA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 174
TABLE 163 INDIA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 174
TABLE 164 INDIA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 174
TABLE 165 INDIA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 175
11.4.5 SOUTH KOREA 175
11.4.5.1 Rising healthcare spending and increasing government initiatives to propel market 175
TABLE 166 SOUTH KOREA: MACROECONOMIC INDICATORS 175
TABLE 167 SOUTH KOREA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 176
TABLE 168 SOUTH KOREA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 176
TABLE 169 SOUTH KOREA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 177
TABLE 170 SOUTH KOREA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 177
TABLE 171 SOUTH KOREA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 178
TABLE 172 SOUTH KOREA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 178
TABLE 173 SOUTH KOREA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 178
11.4.6 AUSTRALIA 179
11.4.6.1 Increasing number of smokers to drive market 179
TABLE 174 AUSTRALIA: MACROECONOMIC INDICATORS 179
TABLE 175 AUSTRALIA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 179
TABLE 176 AUSTRALIA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 180
TABLE 177 AUSTRALIA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 180
TABLE 178 AUSTRALIA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 181
TABLE 179 AUSTRALIA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 181
TABLE 180 AUSTRALIA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 182
TABLE 181 AUSTRALIA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 182
11.4.7 REST OF ASIA PACIFIC 182
TABLE 182 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 183
TABLE 183 REST OF ASIA PACIFIC: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 183
TABLE 184 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 184
TABLE 185 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 184
TABLE 186 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 185
TABLE 187 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 185
TABLE 188 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 185
11.5 LATIN AMERICA 186
11.5.1 IMPACT OF RECESSION ON TRANSDERMAL PATCHES MARKET IN LATIN AMERICA 186
TABLE 189 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 186
TABLE 190 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 187
TABLE 191 LATIN AMERICA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 187
TABLE 192 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 188
TABLE 193 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 188
TABLE 194 LATIN AMERICA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 189
TABLE 195 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 189
TABLE 196 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 189
11.5.2 BRAZIL 190
11.5.2.1 High prevalence of diabetes to propel market 190
TABLE 197 BRAZIL: KEY MACROINDICATORS 190
TABLE 198 BRAZIL: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 190
TABLE 199 BRAZIL: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 191
TABLE 200 BRAZIL: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 191
TABLE 201 BRAZIL: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 191
TABLE 202 BRAZIL: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 192
TABLE 203 BRAZIL: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 192
TABLE 204 BRAZIL: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 192
11.5.3 MEXICO 193
11.5.3.1 Government investments to drive transdermal drug delivery production 193
TABLE 205 MEXICO: KEY MACROINDICATORS 193
TABLE 206 MEXICO: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 193
TABLE 207 MEXICO: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 194
TABLE 208 MEXICO: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 194
TABLE 209 MEXICO: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 195
TABLE 210 MEXICO: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 195
TABLE 211 MEXICO: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 196
TABLE 212 MEXICO: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 196
11.5.4 REST OF LATIN AMERICA 196
TABLE 213 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 197
TABLE 214 REST OF LATIN AMERICA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 197
TABLE 215 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 198
TABLE 216 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 198
TABLE 217 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 199
TABLE 218 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 199
TABLE 219 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 199
 
11.6 MIDDLE EAST & AFRICA 200
11.6.1 GOVERNMENT SUPPORT TO BOOST LOCAL PRODUCTION TO OFFER GROWTH OPPORTUNITIES FOR TRANSDERMAL PATCH MANUFACTURERS 200
11.6.2 IMPACT OF RECESSION ON TRANSDERMAL PATCHES MARKET IN MIDDLE EAST AND AFRICA 200
TABLE 220 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021–2029 (USD MILLION) 201
TABLE 221 MIDDLE EAST & AFRICA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021–2029 (USD MILLION) 201
TABLE 222 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021–2029 (USD MILLION) 202
TABLE 223 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 202
TABLE 224 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021–2029 (USD MILLION) 203
TABLE 225 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 203
TABLE 226 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021–2029 (USD MILLION) 203

12 COMPETITIVE LANDSCAPE 204
12.1 INTRODUCTION 204
TABLE 227 KEY DEVELOPMENTS IN TRANSDERMAL PATCHES MARKET (JANUARY 2020–OCTOBER 2023) 204
12.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS 205
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN TRANSDERMAL PATCHES MARKET 205
12.3 MARKET SHARE ANALYSIS 206
FIGURE 39 TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2022 206
12.4 COMPANY FOOTPRINT 207
12.4.1 FOOTPRINT OF COMPANIES IN TRANSDERMAL PATCHES MARKET 207
12.4.2 PATCH TYPE FOOTPRINT 208
12.4.3 ADHESIVE TYPE FOOTPRINT 209
12.4.4 APPLICATION FOOTPRINT 210
12.4.5 DISTRIBUTION CHANNEL FOOTPRINT 211
12.4.6 END-USER FOOTPRINT 212
12.4.7 REGIONAL FOOTPRINT 213
12.5 TRANSDERMAL PATCHES MARKET: R&D EXPENDITURE 214
FIGURE 40 R&D EXPENDITURE OF KEY PLAYERS IN TRANSDERMAL PATCHES MARKET (2021 VS. 2022) 214
12.6 COMPANY EVALUATION MATRIX 215
12.6.1 STARS 215
12.6.2 EMERGING LEADERS 215
12.6.3 PERVASIVE PLAYERS 215
12.6.4 PARTICIPANTS 215
FIGURE 41 TRANSDERMAL PATCHES MARKET: COMPANY EVALUATION MATRIX, 2022 216
12.7 SME/STARTUP EVALUATION MATRIX 216
12.7.1 PROGRESSIVE COMPANIES 216
12.7.2 STARTING BLOCKS 216
12.7.3 RESPONSIVE COMPANIES 217
12.7.4 DYNAMIC COMPANIES 217
FIGURE 42 TRANSDERMAL PATCHES MARKET: SME/STARTUP EVALUATION MATRIX 217
12.7.5 COMPETITIVE BENCHMARKING 218
TABLE 228 TRANSDERMAL PATCHES MARKET: DETAILED LIST OF KEY STARTUP/SMES 218
12.8 COMPETITIVE SITUATION AND TRENDS 218
12.8.1 PRODUCT LAUNCHES 218
TABLE 229 TRANSDERMAL PATCHES MARKET: PRODUCT LAUNCHES, JANUARY 2020–OCTOBER 2023 218
12.8.2 DEALS 219
TABLE 230 TRANSDERMAL PATCHES MARKET: DEALS, JANUARY 2020–OCTOBER 2023 219
12.8.3 OTHER DEVELOPMENTS 220
TABLE 231 TRANSDERMAL PATCHES MARKET: OTHER DEVELOPMENTS, JANUARY 2020–OCTOBER 2023 220
13 COMPANY PROFILES 221
(Business overview, Products offered, Recent developments & MnM View)*
13.1 KEY PLAYERS 221
13.1.1 HISAMITSU PHARMACEUTICAL CO., INC. 221
TABLE 232 HISAMITSU PHARMACEUTICAL CO., INC.: BUSINESS OVERVIEW 221
FIGURE 43 HISAMITSU PHARMACEUTICAL CO., INC.: COMPANY SNAPSHOT (2022) 222
13.1.2 VIATRIS INC. 225
TABLE 233 VIATRIS INC.: BUSINESS OVERVIEW 225
FIGURE 44 VIATRIS INC.: COMPANY SNAPSHOT (2022) 226
13.1.3 NOVARTIS AG 229
TABLE 234 NOVARTIS AG: BUSINESS OVERVIEW 229
FIGURE 45 NOVARTIS AG: COMPANY SNAPSHOT (2022) 230
13.1.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 232
TABLE 235 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: BUSINESS OVERVIEW 232
FIGURE 46 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2022) 233
13.1.5 JOHNSON & JOHNSON 235
TABLE 236 JOHNSON & JOHNSON: BUSINESS OVERVIEW 235
FIGURE 47 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 236
13.1.6 UCB S.A. 238
TABLE 237 UCB S.A.: BUSINESS OVERVIEW 238
FIGURE 48 UCB S.A.: COMPANY SNAPSHOT (2022) 238
13.1.7 ENDO INTERNATIONAL PLC 240
TABLE 238 ENDO INTERNATIONAL PLC: BUSINESS OVERVIEW 240
FIGURE 49 ENDO INTERNATIONAL PLC: COMPANY SNAPSHOT (2022) 240
13.1.8 LUYE PHARMA GROUP 242
TABLE 239 LUYE PHARMA GROUP: BUSINESS OVERVIEW 242
FIGURE 50 LUYE PHARMA GROUP: COMPANY SNAPSHOT (2022) 242
13.1.9 ABBVIE INC. 244
TABLE 240 ABBVIE INC.: BUSINESS OVERVIEW 244
FIGURE 51 ABBVIE INC.: COMPANY SNAPSHOT (2022) 245
13.1.10 NITTO DENKO CORPORATION 247
TABLE 241 NITTO DENKO CORPORATION: BUSINESS OVERVIEW 247
FIGURE 52 NITTO DENKO CORPORATION: COMPANY SNAPSHOT (2022) 247
13.1.11 CIPLA INC. 249
TABLE 242 CIPLA INC.: BUSINESS OVERVIEW 249
FIGURE 53 CIPLA INC.: COMPANY SNAPSHOT (2022) 249
13.1.12 TEVA PHARMACEUTICAL INDUSTRIES LTD. 251
TABLE 243 TEVA PHARMACEUTICAL INDUSTRIES LTD.: BUSINESS OVERVIEW 251
FIGURE 54 TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2022) 251
13.1.13 AGILE THERAPEUTICS 253
TABLE 244 AGILE THERAPEUTICS: BUSINESS OVERVIEW 253
FIGURE 55 AGILE THERAPEUTICS: COMPANY SNAPSHOT (2022) 253
13.1.14 BAYER AG 255
TABLE 245 BAYER AG: BUSINESS OVERVIEW 255
FIGURE 56 BAYER AG: COMPANY SNAPSHOT (2022) 256
13.1.15 AMNEAL PHARMACEUTICALS LLC 258
TABLE 246 AMNEAL PHARMACEUTICALS LLC: BUSINESS OVERVIEW 258
FIGURE 57 AMNEAL PHARMACEUTICALS LLC: COMPANY SNAPSHOT (2022) 258
13.1.16 HIKMA PHARMACEUTICALS PLC 260
TABLE 247 HIKMA PHARMACEUTICALS PLC: BUSINESS OVERVIEW 260
FIGURE 58 HIKMA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2022) 260
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS 262
13.2.1 ALVOGEN GROUP INC. 262
TABLE 248 ALVOGEN GROUP INC.: COMPANY OVERVIEW 262
13.2.2 SPARSHA PHARMA INTERNATIONAL PVT. LTD. 262
TABLE 249 SPARSHA PHARMA INTERNATIONAL PVT. LTD.: COMPANY OVERVIEW 262
13.2.3 IONTOPATCH 263
TABLE 250 IONTOPATCH: COMPANY OVERVIEW 263
13.2.4 MEDHERANT LIMITED 263
TABLE 251 MEDHERANT LIMITED: COMPANY OVERVIEW 263
13.2.5 ADHEXPHARMA 264
TABLE 252 ADHEXPHARMA: COMPANY OVERVIEW 264
13.2.6 EVERNOW 264
TABLE 253 EVERNOW: COMPANY OVERVIEW 264
13.2.7 LEAD CHEMICAL CO., LTD. 265
TABLE 254 LEAD CHEMICAL CO., LTD.: COMPANY OVERVIEW 265
13.2.8 PURDUE PHARMA L.P. 265
TABLE 255 PURDUE PHARMA L.P.: COMPANY OVERVIEW 265
13.2.9 MUNDIPHARMA INTERNATIONAL 266
TABLE 256 MUNDIPHARMA INTERNATIONAL: COMPANY OVERVIEW 266
13.3 COMPANIES PROVIDING ADHESIVES FOR TRANSDERMAL PATCHES 267
13.3.1 WACKER CHEMIE AG 267
13.3.1.1 Business overview 267
TABLE 257 WACKER CHEMIE AG: BUSINESS OVERVIEW 267
FIGURE 59 WACKER CHEMIE AG: COMPANY SNAPSHOT (2022) 268
13.3.1.2 Products offered 268
13.3.2 ELKEM ASA 269
13.3.2.1 Business overview 269
TABLE 258 ELKEM ASA: BUSINESS OVERVIEW 269
FIGURE 60 ELKEM ASA: COMPANY SNAPSHOT (2022) 270
13.3.2.2 Products offered 270
13.3.3 DUPONT DE NEMOURS, INC. 271
13.3.3.1 Business overview 271
TABLE 259 DUPONT DE NEMOURS, INC.: BUSINESS OVERVIEW 271
FIGURE 61 DUPONT DE NEMOURS, INC.: COMPANY SNAPSHOT (2022) 272
13.3.3.2 Products offered 272
13.3.4 KATECHO, LLC 273
TABLE 260 KATECHO, LLC: COMPANY OVERVIEW 273
13.3.5 POLYMER SCIENCE, INC. 273
TABLE 261 POLYMER SCIENCE, INC.: COMPANY OVERVIEW 273
14 APPENDIX 274
14.1 DISCUSSION GUIDE 274
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 278
14.3 CUSTOMIZATION OPTIONS 280
14.4 RELATED REPORTS 280
14.5 AUTHOR DETAILS 281

★調査レポート[世界の経皮吸収パッチ市場（～2029年）：種類別（貼付剤、マトリックス、リザーバー膜）、粘着剤別（アクリル、シリコーン、ハイドロゲル）、用途別（疼痛、CVS、ホルモン）、流通チャネル別（薬局（オンライン小売、病院））、エンドユーザー別] (コード：MD8869-24)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の経皮吸収パッチ市場（～2029年）：種類別（貼付剤、マトリックス、リザーバー膜）、粘着剤別（アクリル、シリコーン、ハイドロゲル）、用途別（疼痛、CVS、ホルモン）、流通チャネル別（薬局（オンライン小売、病院））、エンドユーザー別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の医療用皮膚粘着剤市場（～2029年）：製品別（アクリル、シリコーン、ゴム、水性）、基材別、種類別（電極、経皮、特殊）、用途別（外科、創傷治療、オストミーシール）、エンドユーザー別（病院、在宅医療）
  • 世界の授乳パッド市場2023-2033：製品タイプ別（再利用型、使い捨て型、シリコーン、ハイドロゲル）、用途別（病院、家庭）、流通チャネル別（小売、eコマース）、地域別
  • 世界の屋根コーティング市場（～2029年）：コーティング種類別（アスファルト、アクリル、シリコーン、エポキシ、ポリウレタン）、屋根種類別（平屋根、低勾配屋根、高勾配屋根、その他）、ソリューション技術別（水性、溶剤系）、エンドユーザー別
  • 世界の感圧接着剤市場（～2029年）：化学別（アクリル、ゴム、シリコーン）、技術別（水性、溶剤系、ホットメルト）、用途別（テープ、ラベル、グラフィック）、産業別（包装、自動車）、地域別
  • 世界の導電性接着剤市場（～2030年）：化学種類別（アクリル、ポリウレタン、シリコーン、エポキシ、その他）、形態別（異方性導電性接着剤、等方性導電性接着剤、その他）、充填材別、用途別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆